Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Tropifexor

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis makes case for NASH candidate tropifexor
    Novartis makes case for NASH candidate tropifexor

    11 Nov 2019

    // L. Parsons PMLIVE

    http://www.pmlive.com/pharma_news/novartis_makes_case_for_nash_candidate_tropifexor_1316558

    L. Parsons PMLIVE
    11 Nov 2019
    Share Share
    Novartis, Pfizer join forces on potentially lucrative fatty liver disease
    Novartis, Pfizer join forces on potentially lucrative fatty liver disease

    30 Oct 2018

    // John Miller REUTERS

    https://www.reuters.com/article/us-novartis-pfizer-liver-disease/novartis-pfizer-join-forces-on-potentially-lucrative-fatty-liver-disease-idUSKCN1N30KZ

    John Miller REUTERS
    30 Oct 2018
    Share Share
    Pfizer Announces Clinical Development Agreement with Novartis to Advance NASH
    Pfizer Announces Clinical Development Agreement with Novartis to Advance NASH

    29 Oct 2018

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20181028005011/en

    BUSINESSWIRE
    29 Oct 2018
    Share Share